Increase the proportion of adolescents with depression who get treatment — MHMD‑06 Data Methodology and Measurement

This objective is a Leading Health Indicator (LHI). Learn about LHIs.

About the National Data

Data

Baseline: 41.4 percent of adolescents aged 12 to 17 years with MDEs received treatment in the past 12 months, as reported in 2018

Target: 46.4 percent

Numerator
Number of adolescents aged 12 to 17 years with a MDE within the past 12 months who received treatment.
Denominator
Number of adolescents aged 12 to 17 years with a MDE in the past 12 months.
Target-setting method

Percentage point improvement

Target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.10.
1
Target-setting method justification
Trend data were evaluated for this objective, but it was not possible to project a target because the trend was flat. A percentage point improvement was calculated using Cohen's h effect size of 0.1. This method was used because it was a clinically meaningful improvement from the baseline.

Methodology

Methodology notes

The Major Depressive Episode (MDE) statistics are annual (last twelve month) prevalence rates. A modified version of the Composite International Diagnostic Interview is administered to assess criteria necessary for a diagnosis of MDE based on DSM IV for adolescents. A person was defined as having had an MDE if he or she had a period of time in the past 12 months when he or she felt depressed or lost interest or pleasure in daily activities for 2 weeks or longer, and had at least five or more of the following nine symptoms in the same 2-week period, in which at least one of the symptoms was a depressed mood or loss of interest or pleasure in daily activities: (1) depressed mood most of the day, nearly every day; (2) markedly diminished interest or pleasure in all or almost all activities most of the day, nearly every day; (3) significant weight loss when not dieting or weight gain or decrease or increase in appetite nearly every day; (4) insomnia or hypersomnia nearly every day; (5) psychomotor agitation or retardation nearly every day; (6) fatigue or loss of energy nearly every day; (7) feelings of worthlessness nearly every day; (8) diminished ability to think or concentrate or indecisiveness nearly every day; and (9) recurrent thoughts of death or recurrent suicide ideation. This definition is based on the definition found in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).


1. Effect size h=0.1 was chosen to correspond with 10% improvement from a baseline of 50%.